Driving revenue growth and earnings growth are two different things.

It's no longer a secret that the Teva Pharmaceutical Industries (NYSE: TEVA) of the past is no more. The Israel-based company is no longer strictly a generic-drug maker, burdened by heavy debt and ...

Teva's transformation is gaining momentum.

Once upon a time, Teva Pharmaceutical Industries Ltd. (TEVA +2.32%) was a stock that many investors didn't want to touch with a 10-foot pole. The pharmaceutical company faced lega ...

Teva Pharmaceutical Industries Limited’s TEVA stock has risen 12.9% in a month. Teva’s stock mainly gained after it announced first-quarter 2025 results on May 7. Teva’s first-quarter results were ...

After a multi-year slump, Teva Pharmaceutical Industries Limited (NYSE: TEVA) is on a roll. Shares of the Israel-based drugmaker have soared more than 130% over the last 12 months. Could Teva's ...

Teva Pharmaceutical Industries Ltd (NYSE:TEVA) stock is trading higher on Wednesday after the company’s first-quarter 2025 financial results. Here are the details. Teva reported revenue of $3.89 ...

View Teva Pharmaceutical Industries Limited Sponsored ADR TEVA stock quote prices, financial information, real-time forecasts, and company news from CNN.

Teva Pharmaceutical Industries Limited’s TEVA shares have risen 21.6% in three months. Over the past few quarters, Teva has successfully launched several biosimilars and other high-value, complex ...

It's no longer a secret that the Teva Pharmaceutical Industries (TEVA +2.32%) of the past is no more. The Israel-based company is no longer strictly a generic-drug maker, burdened ...

Teva is pivoting from generic-drug maker to major pharmaceutical company. Even after more than doubling in price over the past year, shares have more room to run, thanks to the company's robust ...